scholarly article | Q13442814 |
P356 | DOI | 10.1007/S10067-005-0056-6 |
P698 | PubMed publication ID | 16261283 |
P50 | author | Dietmar Fuchs | Q38801487 |
Michael Schirmer | Q42270115 | ||
Katharina Schroecksnadel | Q89374133 | ||
P2093 | author name string | Christiana Winkler | |
Barbara Wirleitner | |||
Christian Duftner | |||
P2860 | cites work | Inhibition of T cell proliferation by macrophage tryptophan catabolism | Q28142922 |
Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation? | Q33740214 | ||
Interferon-gamma-induced tryptophan degradation: neuropsychiatric and immunological consequences | Q34314732 | ||
Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects | Q34535629 | ||
Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan | Q36254619 | ||
Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects | Q38203807 | ||
Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity. | Q39102439 | ||
Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis | Q39104127 | ||
Soluble receptors for tumour necrosis factor in clinical laboratory diagnosis. | Q40595922 | ||
Vascular endothelial adhesion molecules and tissue inflammation. | Q41109400 | ||
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition | Q41264589 | ||
Parallel induction of tetrahydrobiopterin biosynthesis and indoleamine 2,3-dioxygenase activity in human cells and cell lines by interferon-gamma. | Q41993576 | ||
Monocyte-derived dendritic cells release neopterin | Q44253583 | ||
Increased degradation of tryptophan in blood of patients with rheumatoid arthritis | Q44579743 | ||
Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis. | Q45132239 | ||
THE role of indoleamine 2,3-dioxygenase in the anti-tumour activity of human interferon-γin vivo | Q61819257 | ||
Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms | Q61906369 | ||
Urinary neopterin reflects clinical activity in patients with rheumatoid arthritis | Q61906439 | ||
Correlation of interleukin-2 receptor and neopterin secretion in rheumatoid arthritis | Q72650175 | ||
Soluble adhesion molecules in rheumatoid arthritis | Q74046868 | ||
P433 | issue | 3 | |
P921 | main subject | patient | Q181600 |
rheumatoid arthritis | Q187255 | ||
P304 | page(s) | 334-337 | |
P577 | publication date | 2005-11-01 | |
P1433 | published in | Clinical Rheumatology | Q15754927 |
P1476 | title | Tryptophan degradation increases with stage in patients with rheumatoid arthritis | |
P478 | volume | 25 |
Q34541409 | 1-Methyl-tryptophan synergizes with methotrexate to alleviate arthritis in a mouse model of arthritis |
Q35957506 | Addition of an indoleamine 2,3,-dioxygenase inhibitor to B cell-depletion therapy blocks autoreactive B cell activation and recurrence of arthritis in K/BxN mice |
Q35261125 | Amino acid catabolism: a pivotal regulator of innate and adaptive immunity. |
Q48330839 | Antidepressant use among persons with recent-onset rheumatoid arthritis: a nationwide register-based study in Finland |
Q39420155 | Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC. |
Q124900928 | Association between the Platelet-Derived Growth Factor/Platelet-Derived Growth Factor Receptor System and Risk of Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
Q42734436 | Beyond immunosuppression: reconsidering indoleamine 2,3-dioxygenase as a pathogenic element of chronic inflammation. |
Q35840853 | Biomarkers in inflammatory bowel disease: current practices and recent advances |
Q36738206 | Carbon Disulfide (CS2) Interference in Glucose Metabolism from Unconventional Oil and Gas Extraction and Processing Emissions |
Q39104639 | Crinum latifolium leave extracts suppress immune activation cascades in peripheral blood mononuclear cells and proliferation of prostate tumor cells |
Q36642844 | Downregulation of indoleamine-2,3-dioxygenase in cervical cancer cells suppresses tumor growth by promoting natural killer cell accumulation |
Q36245404 | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis. |
Q34873308 | Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction |
Q38127176 | Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis |
Q34776749 | IDO1 and IDO2 non-synonymous gene variants: correlation with crohn's disease risk and clinical phenotype |
Q27022027 | Immunoregulatory molecules are master regulators of inflammation during the immune response |
Q41618398 | Indoleamine 2,3-Dioxygenase Is Dispensable for The Immunomodulatory Function of Stem Cells from Human Exfoliated Deciduous Teeth. |
Q35261110 | Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases |
Q34414152 | Indoleamine 2,3-dioxygenase pathways of pathogenic inflammation and immune escape in cancer |
Q36646476 | Indoleamine-2,3-dioxygenase, an immunosuppressive enzyme that inhibits natural killer cell function, as a useful target for ovarian cancer therapy |
Q36392296 | Inhibition of indoleamine 2,3-dioxygenase-mediated tryptophan catabolism accelerates collagen-induced arthritis in mice |
Q34683824 | Interferon gamma suppresses collagen-induced arthritis by regulation of Th17 through the induction of indoleamine-2,3-deoxygenase |
Q98735567 | Intestinal Dysbiosis and Tryptophan Metabolism in Autoimmunity |
Q48241209 | Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery |
Q34633683 | Kynurenine pathway metabolites in humans: disease and healthy States |
Q36166090 | Metabolite and Lipid Profiling of Biobank Plasma Samples Collected Prior to Onset of Rheumatoid Arthritis |
Q35216385 | Myeloid differentiation primary response protein 88 blockade upregulates indoleamine 2,3-dioxygenase expression in rheumatoid synovial fibroblasts |
Q100526083 | Neopterin and biopterin levels and tryptophan degradation in patients with diabetes |
Q42951260 | Relationship between an increased serum kynurenine/tryptophan ratio and atherosclerotic parameters in hemodialysis patients |
Q35605835 | Serum analysis of tryptophan catabolism pathway: correlation with Crohn's disease activity |
Q46613308 | Serum level of neopterin is not a marker of disease activity in treated rheumatoid arthritis patients |
Q53918432 | Simultaneous analysis of kynurenine and tryptophan in human plasma by capillary electrophoresis with UV detection. |
Q43148161 | Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection |
Q57181096 | Simultaneous determination of tryptophan and its 31 catabolites in mouse tissues by polarity switching UHPLC-SRM-MS |
Q37340475 | The immunoregulatory enzyme IDO paradoxically drives B cell-mediated autoimmunity |
Q97523968 | The role of indoleamine 2,3 dioxygenase 1 in the osteoarthritis |
Q38793765 | The tryptophan/kynurenine pathway, systemic inflammation, and long-term outcome after kidney transplantation |
Q48825054 | Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis |
Q84070984 | Tryptophan degradation and neopterin levels in treated rheumatoid arthritis patients |
Q37013795 | Tryptophan-kynurenine pathway is dysregulated in inflammation, and immune activation. |